Mediterranean diet may reduce the risk of cardiovascular disease in patients with metabolic syndrome

Nearly 50 million Americans have metabolic syndrome, a cluster of risk factors placing them at increased risk of developing cardiovascular disease.

In a review paper, Mohsen Meydani, DVM, PhD, director of the Vascular Biology Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, explores the potential benefits, beyond those achieved with weight loss alone, of a Mediterranean-style diet for patients with metabolic syndrome.

"Consuming a Mediterranean-style diet rich in olive oil, whole grains, fruits, vegetables, and nuts may reduce the risk of cardiovascular disease in patients with metabolic syndrome," says Meydani, who is also a professor at the Friedman School of Nutrition Science and Policy at Tufts. "Evidence suggests that this effect may be due to actions on two of the integral components of cardiovascular disease - inflammation and dysfunction of the cells lining the inner surfaces of blood vessels."

Meydani focuses on the results of a two-year intervention trial conducted in Italy. Subjects were divided into two groups. Both groups lost modest amounts of weight while following reduced-calorie diets and exercising, but the group eating a Mediterranean-style diet had greater improvements in several components of the metabolic syndrome, such as total cholesterol, triglycerides, and blood sugar.

Metabolic syndrome is associated with an increased risk of cardiovascular disease and death, but these outcomes can be prevented through early detection and modification of risk factors.

"Although caloric restriction and body weight reduction remain a primary approach for treating metabolic syndrome patients, intervention with a Mediterranean-style diet combined with moderate exercise might be a strategy to enhance the cardiovascular benefits of weight loss," Meydani concludes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers discover new target for treating atherosclerosis